Clinical and pharmacological group: & nbsp

Dermatotropona funds

Included in the formulation
АТХ:

D.11.A.X   Other preparations for the treatment of skin diseases

Pharmacodynamics:

The drug softens the skin, helps to retain water in the skin, increases its elasticity.

Pharmacokinetics:

Insignificant bioavailability, biotransformed in the intestine, half-life of 70 minutes, excreted by the kidneys.

Indications:

Зskin abnormalities accompanied by excessive cornification: ichthyosis and ichthyosiform dermatoses, keratoderma, psoriasis, chronic eczema, Devergie's disease, follicular keratosis, hyperkeratotic forms of fungal diseases; omozolelosti, dry skin.

To soften the skin when removing horny layers with warts (before removal) and for softening the nail plates in order to facilitate their cutting and processing with ingrown nails, onychomycosis, onychriphosis, onychodystrophy, firm nails.

I.B00-B09.B07   Viral Warts

I.B35-B49.B35.1   Mycosis of nails

XII.L40-L45.L40   Psoriasis

XII.L40-L45.L44.0   Pityiaris red hair frangible

XII.L60-L75.L60   Diseases of the nails

XII.L60-L75.L60.8   Other nail diseases

XII.L80-L99.L84   Corn and calligraphy

XII.L80-L99.L85   Other epidermal thickenings

XII.L80-L99.L85.0   Acquired ichthyosis

XII.L80-L99.L85.3   Skin conjunctival

XII.L80-L99.L87.0   Keratosis is follicular and parafollicular, penetrating the skin [Kirl's disease]

Contraindications:

Hypersensitivity.

Carefully:

Do not apply to large areas of the skin when renal, hepatic and cardiovascular insufficiency.

Pregnancy and lactation:

Use of the drug is possible only after consulting a doctor. It is not recommended to apply on large surfaces.

Application is possible if the potential benefit to the mother exceeds the potential risk to the fetus or child.

Dosing and Administration:

Outwardly. Locally 2 times a day, with strong peeling, you can use an occlusive dressing. When warts - for 2-8 hours under the adhesive plaster, when applied to the nails (before cutting) - for 20-30 minutes.

Side effects:

Allergic reactions. When used in an acute period of skin disease in some cases, itching and reddening of the skin in the places of application of the drug is possible, which requires its temporary cancellation until the severity of the process is reduced.

Overdose:

Not described.

Interaction:

Strengthens the resorption of funds for external use.

Do not use simultaneously with other keratolytic ointments.

Special instructions:

Avoid contact with mucous membranes.

Impact on the ability to drive vehicles and manage mechanisms

Does not affect the ability to drive vehicles and drive mechanisms.

Instructions
Up